Skip to main content
. 2019 Aug 16;20(16):3982. doi: 10.3390/ijms20163982

Figure 6.

Figure 6

Effects of FGFR inhibitor PD173074 on motility and proliferation. (a) Overall average velocities of U-118 MG cells treated with the FGFR inhibitor. (b) Overall average velocities of T98G/shL1 cells treated with inhibitor. (c) Overall average velocities of T98G/dFGFR cells treated with inhibitor. (d) U-118 MG cell proliferation (% S phase population) with the addition of the inhibitor. (e) T98G/shL1 cell S phase population when treated with inhibitor. (f) T98G/dFGFR cell S phase population when treated with inhibitor, * p < 0.05, ** p < 0.01.